Veterinary Medicine Information website

Bovalto Respi Intranasal, Nasal spray, lyophilisate and solvent for suspension

Authorised
  • Bovine respiratory syncytial virus, strain BIO 24/A, Live
  • Bovine parainfluenza virus 3, strain BIO 23/A, Live
Download as PDF

Product identification

Medicine name:
Bovalto Respi Intranasal, Nasal spray, lyophilisate and solvent for suspension
Active substance:
  • Bovine respiratory syncytial virus, strain BIO 24/A, Live
  • Bovine parainfluenza virus 3, strain BIO 23/A, Live
Target species:
  • Cattle
Route of administration:
  • Nasal use

Product details

Active substance and strength:
  • Bovine respiratory syncytial virus, strain BIO 24/A, Live
    7.50
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Bovine parainfluenza virus 3, strain BIO 23/A, Live
    6.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Nasal spray, lyophilisate and solvent for suspension
Withdrawal period by route of administration:
  • Nasal use
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AD07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • Glass Vial 1 x 5.0 Dose
  • Glass Vial 5 x 5.0 Dose
  • Glass Vial 1 x 10.0 Dose
  • Glass Vial 5 x 1.0 Dose

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.11947.01.1
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0141/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • France
  • Germany
  • Greece
  • Ireland
  • Italy
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 4/03/2026
Download